• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,717.62 318.90
( 0.42%)
Global Indices
Nasdaq
50,087.63 373.42
(0.75%)
Dow Jones
7,522.46 57.21
(0.77%)
Hang Seng
61,141.50 -1,512.55
(-2.41%)
Nikkei 225
10,362.65 37.30
(0.36%)
Forex
USD-INR
95.64 0.03
(0.04%)
EUR-INR
112.06 -0.23
(-0.21%)
GBP-INR
129.33 -0.17
(-0.13%)
JPY-INR
0.61 0.00
(-0.10%)

EQUITY - MARKET SCREENER

Advanced Enzyme Technologies Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
540025
INE837H01020
63.3737836
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ADVENZYMES
30.27
4087.13
EPS(TTM)
Face Value()
Div & Yield %
12.06
2
0.37
 

MCX receives SEBI approval for incorporation of coal exchange company
Apr 20,2026

Multi Commodity Exchange of India (MCX) announced that it has received approval from the Securities and Exchange Board of India (SEBI) to invest in a proposed Coal Exchange company. This marks MCX's significant commitment into the energy sector and deepening commodity ecosystem. With highly liquid derivatives contracts on crude oil, natural gas and the launch last year of its electricity futures contract, the foray into coal via the new entity, will make MCX's energy presence comprehensive. It is aimed at developing a regulated, transparent, technology-driven market platform for buying and selling coal that facilitates an efficient and robust price discovery for coal in the country.

Pursuant to SEBI's approval granted on 17 April 2026, MCX plans to incorporate a new subsidiary, likely to be named ‘MCX Coal Exchange' or ‘MCX Coal Exchange of India.'